News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
Alnylam Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs
April 28, 2016
·
4 min read
Drug Development
Alnylam’s John Maraganore Provides Leadership for RNAi Development and Biotech Industry
April 1, 2016
·
7 min read
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
·
3 min read
Deals
Three Potential Takeover Targets for Amgen
March 10, 2016
·
3 min read
Job Trends
Alnylam to Build $200 Million Site in Massachusetts that Will Employ 200+ Workers
February 12, 2016
·
2 min read
Job Trends
Alnylam’s Human Resources Boss Provides Hiring Strategy, Planning to Hire 1,500 By 2020
December 9, 2015
·
3 min read
Deals
Why Amgen Should Turn Its Attention to Alnylam
November 13, 2015
·
3 min read
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
·
4 min read
Business
Former Sanofi Exec and Viehbacher Protoge to Join Alnylam as Senior VP
June 8, 2015
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
March 5, 2026
·
5 min read
Press Releases
Alnylam Receives Positive Recommendation From Canada’s Drug Agency (CDA) for the Public Reimbursement of AMVUTTRA® (vutrisiran injection), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
March 2, 2026
·
6 min read
Press Releases
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
February 23, 2026
·
1 min read
Press Releases
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
February 12, 2026
·
19 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
January 29, 2026
·
1 min read
Press Releases
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
January 12, 2026
·
11 min read
Press Releases
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
2 min read
Press Releases
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
December 18, 2025
·
2 min read
Press Releases
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics
December 18, 2025
·
10 min read
Press Releases
Alnylam Announces Health Canada Approval of AMVUTTRA® (vutrisiran), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
December 17, 2025
·
10 min read
